Moody's
MCO NYSE Financial Exchanges & Data Financials FY2016βFY2025
Moody's revenue rose 8.9% to $7.7 billion in fiscal 2025. Its operating margin was 43.4%, up from 40.6% a year earlier. Free cash flow was $2.6 billion, up 2.1%. It paid out $2.3 billion in dividends and buybacks, 90% of free cash flow. The diluted share count fell 1.5%.
What Moody's does
No business description yet.
- Legal name
- Moodyβs Corporation
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-009136
0001059556
Revenue and margins
Moody's had $7.7B of revenue in fiscal 2025, up 8.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 29.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.6B in fiscal 2025, 33.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Moody's returned $2.3B to shareholders in fiscal 2025, 90% of free cash flow. The diluted share count fell 1.5%.
Value Moody's yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.5B and divides by 179.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 29.5x Β· peers 26.5x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Moody's can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.9B | $1.9B | $2.2B | $3.0B | $2.4B |
| Debt incl. finance leases | $7.4B | $7.4B | $7.0B | $7.4B | $7.0B |
| Net debt / EBITDA | 1.8x | 2.5x | 1.9x | 1.4x | 1.2x |
| Debt / equity | 2.7x | 2.9x | 2.1x | 2.1x | 1.7x |
| Interest coverage | 17.6x | 9.5x | 7.6x | 10.3x | 14.3x |
| Current ratio | 1.6x | 1.7x | 1.7x | 1.5x | 1.7x |
| Quick ratio | 1.6x | 1.7x | 1.7x | 1.5x | 1.7x |
| Total assets | $14.7B | $14.3B | $14.6B | $15.5B | $15.8B |
| Total liabilities | $11.8B | $11.7B | $11.1B | $11.8B | $11.6B |
| Shareholders' equity | $2.7B | $2.5B | $3.3B | $3.6B | $4.1B |
| Net debt (β = net cash) | $5.5B | $5.5B | $4.8B | $4.5B | $4.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$6.8M
3 insiders
Of sales under plans
71%
$4.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 923 | $455.00 | $0.4M | Form 4 |
| Sep 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $501.89 | $0.7M | Form 4 |
| Aug 3, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $484.30 | $0.7M | Form 4 |
| Jul 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 157 | $455.49 | $0.1M | Form 4 |
| Jul 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $455.49 | $0.7M | Form 4 |
| Jun 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 158 | $453.67 | $0.1M | Form 4 |
| Jun 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $453.67 | $0.7M | Form 4 |
| May 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 158 | $466.39 | $0.1M | Form 4 |
| May 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $466.39 | $0.7M | Form 4 |
| Apr 1, 2026 | Richard G SteeleSVP - General Counsel | Sold plan | 158 | $437.77 | $0.1M | Form 4 |
| Apr 1, 2026 | Robert FauberPresident and CEO, Director | Sold plan | 1,467 | $437.77 | $0.6M | Form 4 |
| Mar 4, 2026 | Michael L WestPresident, Moody's Investors | Sold | 4,250 | $473.72 | $2.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 9 / 9 | 7 / 9 | 9 / 9 |
| Accruals ratio | β3.8% | β5.2% | β2.8% |
| Altman Z'' | 5.40 | 5.67 | 6.39 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Moody's MCO | $83.8B | 8.9% | 43.4% | 33.4% | 31.1% | 29.5x | 9 | |
| Nasdaq NDAQ | $57.8B | 11.7% | 28.2% | 24.1% | 9.5% | 28.0x | 9 | Compare β |
| Coinbase COIN | $43.3B | 9.4% | 20.0% | 31.9% | 14.5% | β | 4 | Compare β |
| CME Group CME | $109.6B | 6.4% | 64.9% | 64.3% | 11.9% | 25.1x | 7 | Compare β |
| Cboe Global Markets CBOE | $35.7B | 15.1% | 31.1% | 35.7% | 22.8% | 26.5x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.6B | $4.2B | $4.4B | $4.8B | $5.4B | $6.2B | $5.5B | $5.9B | $7.1B | $7.7B |
| Gross profit | β | $3.0B | $3.2B | $3.4B | $3.9B | $4.6B | $3.9B | $4.2B | $5.1B | $5.7B |
| Research and development | $40.1M | $42.0M | $51.1M | β | β | β | β | β | β | β |
| Operating income | $651M | $1.8B | $1.9B | $2.0B | $2.4B | $2.8B | $1.9B | $2.1B | $2.9B | $3.4B |
| Interest expense | $137M | $158M | $183M | $167M | $132M | $162M | $198M | $281M | $280M | $235M |
| Pretax income | $558M | $1.8B | $1.7B | $1.8B | $2.2B | $2.8B | $1.8B | $1.9B | $2.7B | $3.1B |
| Income tax | $282M | $779M | $352M | $381M | $452M | $541M | $386M | $327M | $640M | $668M |
| Net income | $267M | $1.0B | $1.3B | $1.4B | $1.8B | $2.2B | $1.4B | $1.6B | $2.1B | $2.5B |
| Diluted EPS | $1.36 | $5.15 | $6.74 | $7.42 | $9.39 | $11.78 | $7.44 | $8.73 | $11.26 | $13.67 |
| Diluted shares | 0.20B | 0.19B | 0.19B | 0.19B | 0.19B | 0.19B | 0.18B | 0.18B | 0.18B | 0.18B |
| Cash flow | ||||||||||
| Cash from operations | $1.3B | $755M | $1.5B | $1.7B | $2.1B | $2.0B | $1.5B | $2.2B | $2.8B | $2.9B |
| Capital expenditure | $115M | $91.0M | $91.0M | $69.0M | $103M | $139M | $283M | $271M | $317M | $326M |
| Free cash flow | $1.1B | $664M | $1.4B | $1.6B | $2.0B | $1.9B | $1.2B | $1.9B | $2.5B | $2.6B |
| Depreciation and amortization | $127M | $158M | $192M | $200M | $220M | $257M | $331M | $373M | $431M | $480M |
| Stock-based compensation | $98.1M | $123M | $130M | $136M | $154M | $175M | $169M | $193M | $220M | $232M |
| Acquisitions | $80.8M | $3.5B | $289M | $162M | $897M | $2.2B | $97.0M | $3.0M | $221M | $227M |
| Share buybacks | $739M | $200M | $203M | $991M | $503M | $750M | $983M | $490M | $1.3B | $1.6B |
| Dividends paid | $285M | $290M | $337M | $378M | $420M | $463M | $515M | $564M | $620M | $701M |
| Dividends and buybacks | $1.0B | $490M | $540M | $1.4B | $923M | $1.2B | $1.5B | $1.1B | $1.9B | $2.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.2B | $1.2B | $1.8B | $1.9B | $2.7B | $1.9B | $1.9B | $2.2B | $3.0B | $2.4B |
| Total debt | $3.4B | $5.5B | β | $5.6B | $6.4B | $7.4B | $7.4B | $7.0B | $7.4B | $7.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $3.3B | $2.6B | $3.4B | $3.7B | $4.5B | $4.0B | $4.1B | $4.3B | $5.3B | $5.2B |
| Current liabilities | $2.4B | $2.1B | $2.1B | $1.9B | $2.2B | $2.5B | $2.4B | $2.5B | $3.6B | $3.0B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $326M | $325M | $320M | $292M | $278M | $347M | $502M | $603M | $656M | $722M |
| Total assets | $5.3B | $8.6B | $9.5B | $10.3B | $12.4B | $14.7B | $14.3B | $14.6B | $15.5B | $15.8B |
| Total liabilities | $6.4B | $8.7B | $8.9B | $9.4B | $10.6B | $11.8B | $11.7B | $11.1B | $11.8B | $11.6B |
| Shareholders' equity | β$1.2B | β$328M | $459M | $612M | $1.6B | $2.7B | $2.5B | $3.3B | $3.6B | $4.1B |
| Margins | ||||||||||
| Gross margin | β | 71.1% | 72.0% | 71.3% | 72.5% | 73.7% | 70.5% | 71.5% | 72.6% | 74.4% |
| Operating margin | 18.1% | 43.3% | 42.0% | 41.4% | 44.5% | 45.7% | 34.4% | 36.1% | 40.6% | 43.4% |
| EBITDA margin | 21.6% | 47.1% | 46.4% | 45.5% | 48.6% | 49.9% | 40.5% | 42.4% | 46.6% | 49.6% |
| Net margin | 7.4% | 23.8% | 29.5% | 29.5% | 33.1% | 35.6% | 25.1% | 27.2% | 29.0% | 31.9% |
| FCF margin | 31.7% | 15.8% | 30.8% | 33.3% | 38.0% | 30.0% | 21.8% | 31.8% | 35.6% | 33.4% |
| Returns | ||||||||||
| Return on capital | β | 47.2% | β | β | 38.2% | 32.9% | 17.7% | 21.5% | 26.6% | 31.1% |
| Return on capital employed | 19.2% | 38.6% | 26.8% | 25.3% | 25.8% | 25.4% | 15.6% | 17.7% | 23.9% | 27.1% |
| Return on equity | β | β | β | 265.6% | 163.0% | 103.1% | 52.4% | 55.1% | 59.8% | 64.6% |
| Return on assets | 5.1% | 14.4% | 14.5% | 14.4% | 15.7% | 16.4% | 9.5% | 11.1% | 13.7% | 15.7% |
| Growth | ||||||||||
| Revenue growth | 3.4% | 16.6% | 5.7% | 8.7% | 11.2% | 15.8% | β12.1% | 8.2% | 19.8% | 8.9% |
| Net income growth | β71.7% | 275.5% | 30.9% | 8.6% | 25.0% | 24.5% | β37.9% | 17.0% | 28.1% | 19.5% |
| EPS growth | β70.6% | 278.7% | 30.9% | 10.1% | 26.6% | 25.5% | β36.8% | 17.3% | 29.0% | 21.4% |
| FCF growth | 3.2% | β42.0% | 106.3% | 17.2% | 27.2% | β8.7% | β36.2% | 57.9% | 34.1% | 2.1% |
| Share count change | β3.9% | β0.6% | 0.1% | β1.4% | β1.2% | β0.7% | β1.7% | β0.4% | β0.7% | β1.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.5x | 2.2x | β | 1.7x | 1.4x | 1.8x | 2.5x | 1.9x | 1.4x | 1.2x |
| Debt / equity | β | β | β | 9.1x | 4.1x | 2.7x | 2.9x | 2.1x | 2.1x | 1.7x |
| Interest coverage | 4.8x | 11.5x | 10.2x | 12.0x | 18.1x | 17.6x | 9.5x | 7.6x | 10.3x | 14.3x |
| Current ratio | 1.3x | 1.3x | 1.6x | 1.9x | 2.0x | 1.6x | 1.7x | 1.7x | 1.5x | 1.7x |
| Quick ratio | 1.3x | 1.3x | 1.6x | 1.9x | 2.0x | 1.6x | 1.7x | 1.7x | 1.5x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.2% | 2.2% | 2.1% | 1.4% | 1.9% | 2.2% | 5.2% | 4.6% | 4.5% | 4.2% |
| Stock comp / revenue | 2.7% | 2.9% | 2.9% | 2.8% | 2.9% | 2.8% | 3.1% | 3.3% | 3.1% | 3.0% |
| Payouts / FCF | 89.5% | 73.8% | 39.4% | 85.2% | 45.2% | 65.0% | 125.8% | 56.1% | 75.8% | 89.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 5.0 | β | β | 8.0 | 6.0 | 6.0 | 9.0 | 7.0 | 9.0 |
| Altman Z'' | 5.8 | 4.6 | 5.2 | 5.6 | 5.6 | 5.1 | 5.0 | 5.4 | 5.7 | 6.4 |
| Accruals ratio | β19.0% | 3.5% | β1.7% | β2.6% | β3.3% | 1.5% | β0.7% | β3.8% | β5.2% | β2.8% |
Source: SEC EDGAR XBRL filings (CIK 0001059556). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.